Disorders of sexual preference

F5_SEXPREF

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — F65 Hospital discharge: ICD-9 — 302[1-2]\|3024\|3028\|3029 Hospital discharge: ICD-8 — 302 Hospital discharge: excluded ICD-8 — 3023 Cause of death: ICD-10 — F65 Cause of death: ICD-9 — 302[1-2]\|3024\|3028\|3029 Cause of death: ICD-8 — 302 Cause of death: excluded ICD-8 — 3023 2 out of 7 registries used, show all original rules.	82
4. Check minimum number of events None	82
5. Include endpoints None	82
6. Filter based on genotype QC (FinnGen only)	73

Control definitions (FinnGen only)

Control exclude: F5_PERSOBEH

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: F63-F69
Name in latin: Perturbationes praeferentiae sexualis

NAME	F5_SEXPREF
CONTROL_EXCLUDE	F5_PERSOBEH
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	F65
HD_ICD_9	302[1-2]\|3024\|3028\|3029
HD_ICD_8	302
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL	3023
COD_MAINONLY
COD_ICD_10	F65
COD_ICD_9	302[1-2]\|3024\|3028\|3029
COD_ICD_8	302
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL	3023
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Disorders of sexual preference based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	921	154	755
Only index persons	675	116	559
Unadjusted period prevalence (%)
Whole population	0.02	0.00	0.02
Only index persons	0.02	0.00	0.02
Median age at first event (years)
Whole population	31.68	28.72	32.05
Only index persons	29.04	23.76	30.13

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	73	10	63
Unadjusted period prevalence (%)	0.03	0.00	0.03
Median age at first event (years)	35.18	29.01	36.16

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

No data

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
82: Matched controls
820

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

12.5

22.9

F65.4

ICD-10 Finland

Paedophilia

+∞

18.4

30200

ICD-8 Finland

Sexual deviation, Homosexuality

+∞

13.9

N06AB03

ATC

fluoxetine; oral

7.4

13.3

30299

ICD-8 Finland

Sexual deviation, Unspecified

+∞

12.8

N03AG01

ATC

valproic acid; systemic, rectal

14.1

11.3

N06AB04

ATC

citalopram; systemic

5.3

11.1

N05AH03

ATC

olanzapine; systemic

10.9

N05BA04

ATC

oxazepam; oral

4.8

10.7

105

N05AH04

ATC

quetiapine; oral

5.0

10.0

30041

ICD-8 Finland

Neuroses, Depressiva

112.5

9.6

F61.0

ICD-10 Finland

Mixed personality disorders

+∞

9.6

T36

ICD-10 Finland

Poisoning by systemic antibiotics

18.4

9.4

N05CD07

ATC

temazepam; oral

5.3

8.8

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

31.3

8.7

30188

ICD-8 Finland

Personality disorders, Alia definita

+∞

8.5

N05BA01

ATC

diazepam; systemic, rectal

5.0

8.2

N05AD01

ATC

haloperidol; systemic

15.3

7.7

F65.0

ICD-10 Finland

Fetishism

+∞

7.4

N05AA02

ATC

levomepromazine; systemic

8.5

7.1

N05AF03

ATC

chlorprothixene; systemic

18.7

6.9

N05AB03

ATC

perphenazine; systemic, rectal

13.9

6.8

J18.9

ICD-10 Finland

Pneumonia, unspecified

3.5

6.7

127

N05AA01

ATC

chlorpromazine; systemic, rectal

19.9

6.4

F10.26

ICD-10 Finland

Alcohol dependence periodic alcoholism

29.2

6.4

30170

ICD-8 Finland

Personality disorders, Antisocial

+∞

6.3

F65.9

ICD-10 Finland

Disorder of sexual preference, unspecified

+∞

6.3

K08.3

ICD-10 Finland

Retained dental root

6.1

F32.9

ICD-10 Finland

Depressive episode, unspecified

4.6

6.0

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(40758558) Short blood count panel - Blood

161

3.05

5.55

12.7

5.6

—

(3028707) Methadone [Presence] in Urine by Screen method

9.69

4.38

5.8

2.0

—

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

9.42

3.85

35.1

18.3

1035.86

888.38

nmol/l

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

9.42

3.85

27.1

13.3

626.43

620.63

nmol/l

—

(3028626) Oxygen [Partial pressure] in Capillary blood

6.84

3.25

14.6

2.6

7.59

8.51

kpa

—

(3021901) Oxygen saturation in Capillary blood

6.37

2.75

2.5

2.8

—

(3023368) Bacteria identified in Blood by Culture

173

2.16

2.66

4.7

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

277

2.06

2.61

9.1

8.9

1.21

mmol/l

0.03

238

(3011288) Drugs identified in Urine by Screen method

4.68

2.53

6.4

1.9

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

3.91

2.43

5.8

1.5

—

(3007853) Bacteria identified in Skin by Aerobe culture

2.48

2.27

2.1

1.7

—

(3014576) Chloride [Moles/volume] in Serum or Plasma

2.41

2.26

10.0

7.9

104.38

104.57

mmol/l

0.05

(3000764) Benzodiazepines [Presence] in Urine

3.24

2.22

5.2

1.7

—

(3016879) Cocaine [Presence] in Urine

3.24

2.22

5.2

1.7

—

(3028300) Cannabinoids [Presence] in Urine

3.24

2.22

5.7

1.7

—

(3027008) Opiates [Presence] in Urine

3.24

2.22

5.2

1.7

—

(3027944) Amphetamines [Presence] in Urine

3.24

2.22

5.2

1.7

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

3.93

2.20

1.1

1.4

—

(40760892) CBC W Ordered Manual Differential panel - Blood

299

1.92

2.19

10.1

6.2

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

4.23

2.08

2.5

2.3

29.47

24.61

mmol/l

—

(3021589) Normoblasts [#/volume] in Blood

303

1.88

2.07

14.1

9.2

0.00

0.01

e9/l

0.36

246

(3009508) Creatinine [Moles/volume] in Urine

206

1.91

2.02

3.8

3.2

9.85

8.69

mmol/l

0.35

178

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

2.39

2.02

1.1

2.2

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

2.43

1.96

1.1

2.0

—

(3018095) Leukocytes [#/volume] in Urine

221

1.83

1.81

5.6

3.0

166.05

47.67

e6/l

0.68

163

(3026008) Bacteria identified in Urine by Culture

129

1.96

1.80

3.2

2.9

—

(1761868) Lipid panel - Serum or Plasma

260

0.48

1.77

5.3

2.8

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

207

1.80

1.70

2.5

1.8

86.99

95.77

pmol/l

0.56

115

(3011397) Hemoglobin [Presence] in Urine by Test strip

125

1.91

1.64

3.5

—

(3009261) Glucose [Presence] in Urine by Test strip

300

1.73

1.63

3.2

3.4

0.43

0.00

estimate

—

(3000991) Gas panel - Venous blood

2.29

1.52

13.5

8.3

—

(3021601) Nitrite [Presence] in Urine by Test strip

296

1.69

1.50

4.7

4.5

0.00

estimate

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

2.47

1.48

3.3

4.3

128.11

132.23

g/l

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

105

1.92

1.48

5.7

2.3

0.89

1.07

e6/l

—

(3000492) Spirometry study

2.12

1.48

1.6

1.4

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

2.34

1.46

10.7

2.9

6.12

5.10

kpa

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

3.06

1.38

1.2

—

(3012516) Albumin [Mass/volume] in Urine

192

1.70

1.37

2.8

3.3

44.78

405.23

mg/l

0.56

134

(3004588) Protein electrophoresis panel - Serum or Plasma

2.50

1.33

1.3

2.4

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

2.61

1.33

2.2

1.6

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

1.87

1.29

6.1

2.3

2.49

1.51

e6/l

—

(3052851) Hemolysis interference index of Serum or Plasma

2.73

1.23

2.0

3.6

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

2.73

1.23

1.2

2.5

—

(3022621) pH of Urine by Test strip

2.22

1.22

1.6

2.2

—

(3039443) Prostate specific Ag panel - Serum or Plasma

0.00

1.19

0.0

1.4

—

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

2.45

1.15

4.7

3.8

47.87

60.83

—

(3030467) Casts [#/volume] in Urine by Automated count

191

1.62

1.15

5.3

2.5

0.53

0.28

e6/l

0.48

141

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

237

1.57

1.13

5.1

2.7

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

2.30

1.11

3.9

4.6

25.61

24.43

mmol/l

—

(3009343) pH of Capillary blood

2.07

1.08

11.3

2.9

—

7.44

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

2.01

1.06

2.6

1.8

341.00

359.09

nmol/l

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

2.16

1.05

3.3

2.4

0.54

0.71

—

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

2.09

1.03

3.3

2.4

1.20

1.56

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

641

1.80

1.00

5.6

4.3

6.33

6.11

mmol/l

0.57

583

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

137

1.61

0.96

2.4

1.6

0.68

0.84

mg/l

0.36

105

(36304419) Bacteria [Presence] in Urine

181

1.55

0.95

5.4

2.4

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

2.23

0.93

2.0

1.1

—

(3018418) pH of Serum or Plasma

174

1.54

0.91

3.5

3.6

7.39

7.40

—

(3022217) INR in Platelet poor plasma by Coagulation assay

304

1.47

0.90

7.2

13.3

1.17

1.23

inr

—

(3035350) Ketones [Presence] in Urine by Test strip

295

1.46

0.89

3.4

0.00

estimate

—

(3037467) Urinalysis macro (dipstick) panel - Urine

415

1.45

0.84

5.6

3.6

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

224

1.46

0.81

2.8

2.5

178.83

161.10

ug/l

0.16

208

(3001019) Free T4 and TSH panel - Serum or Plasma

0.00

0.80

0.0

1.2

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

117

1.57

0.80

1.5

1.8

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

1.82

0.78

1.2

1.6

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

1.92

0.76

1.9

1.1

—

(3020682) Albumin/Creatinine [Ratio] in Urine

208

1.44

0.76

3.3

3.8

4.98

11.66

mg/mmol

0.93

141

(3020891) Body temperature

2.06

0.74

4.2

4.9

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

103

1.56

0.71

1.4

1.6

—

(3019832) Treponema pallidum Ab [Presence] in Serum

1.73

0.70

1.3

1.7

—

(3022948) Iron [Moles/volume] in Serum or Plasma

1.57

0.69

1.7

2.4

11.58

14.20

umol/l

0.72

(3004789) Transferrin [Mass/volume] in Serum or Plasma

1.59

0.68

1.6

2.4

2.41

2.37

g/l

0.07

(3017143) Hepatitis C virus Ab [Presence] in Serum

1.61

0.67

2.8

1.8

—

(3044889) 12 lead EKG panel

468

1.37

0.64

4.4

3.7

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

1.63

0.63

1.4

1.5

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

1.64

0.62

2.7

3.0

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1.52

0.61

1.6

2.0

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

1.56

0.60

3.3

1.8

—

(3002582) Erythrocytes [#/volume] in Urine

207

1.37

0.60

5.5

2.6

50.97

40.41

e6/l

0.09

156

(3000494) Fungus identified in Specimen by Culture

1.59

0.60

2.2

1.8

—

(3022313) Gas panel - Capillary blood

1.77

0.59

16.5

2.8

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

255

1.35

0.58

3.4

3.8

38.57

27.79

ng/l

0.20

179

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

1.47

0.52

1.2

6.86

26.63

iu/ml

—

(3019225) pH of Specimen

1.44

0.46

4.0

3.9

—

(4200892) Spirometry reversibility

1.50

0.44

1.3

1.5

—

(40768804) Tissue Pathology biopsy report

213

0.75

0.44

3.0

2.0

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

0.00

0.41

0.0

1.7

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

0.00

0.41

0.0

1.6

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

0.00

0.41

0.0

1.7

—

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

0.00

0.41

0.0

1.2

—

(40768800) Prostate Pathology biopsy report

0.00

0.40

0.0

1.2

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

642

1.35

0.39

19.8

11.5

84.64

84.75

ml/min/173m2

0.01

528

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

665

1.36

0.37

19.8

13.3

17.56

24.25

mg/l

1.62

523

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

1.42

0.36

11.5

14.5

6.34

4.89

kpa

—

(40768797) Stomach Pathology biopsy report

1.36

0.32

1.3

—

(3002256) Pathology report gross observation

0.67

0.27

1.8

1.2

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

1.30

0.27

1.7

—

(3003396) Base excess in Arterial blood by calculation

1.26

0.26

12.7

14.6

1.73

1.28

mmol/l

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

695

1.29

0.25

26.8

15.2

139.15

139.67

mmol/l

1.02

677

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

653

1.24

0.24

4.5

3.9

1.58

1.35

mmol/l

1.16

598

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

717

1.33

0.22

15.0

9.6

38.32

30.53

u/l

0.42

693

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

0.00

0.21

0.0

1.2

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

0.00

0.21

0.0

1.9

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

0.00

0.21

0.0

1.9

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

0.00

0.21

0.0

1.8

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

0.00

0.21

0.0

3.0

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

0.00

0.21

0.0

1.2

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

0.00

0.21

0.0

1.2

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

0.00

0.21

0.0

2.0

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

0.00

0.21

0.0

1.2

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

0.00

0.21

0.0

2.0

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

0.00

0.21

0.0

2.0

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

0.00

0.21

0.0

1.8

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

0.00

0.21

0.0

1.3

—

600.83

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

0.00

0.21

0.0

1.1

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

0.00

0.21

0.0

1.7

—

(40760888) Immunoglobulin light chains.free panel - Serum

0.00

0.21

0.0

3.5

—

(3023419) Bacteria identified in Sputum by Culture

0.00

0.21

0.0

2.5

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

0.00

0.20

0.0

1.7

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

0.00

0.20

0.0

1.6

—

(4035726) Immunohistochemistry procedure

1.22

0.20

2.0

1.3

—

(3041096) Erythrocytes [Presence] in Urine by Automated

174

0.83

0.20

3.3

3.0

—

(40761535) Cells panel - Urine sediment

1.19

0.20

3.5

3.8

—

(3003694) ABO and Rh group [Type] in Blood

167

1.18

0.19

1.6

1.3

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

1.25

0.18

1.2

1.6

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

0.74

0.17

1.0

1.5

—

(3037522) Nuclear Ab [Titer] in Serum

0.74

0.17

1.0

1.3

—

350.59

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

395

0.88

0.17

3.2

4.2

1.59

2.48

ug/l

0.53

357

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

415

1.13

0.17

2.4

3.2

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

1.22

0.14

1.8

2.4

18.88

24.06

—

(3042936) Bacteria identified in Isolate by Culture

1.20

0.14

1.8

2.3

—

(3007164) IgA [Mass/volume] in Serum or Plasma

124

1.16

0.12

1.1

1.3

2.81

2.32

g/l

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

309

0.90

0.11

3.2

3.9

21.93

22.00

0.01

134

(3019060) Gas panel - Arterial blood

1.12

0.10

1.4

14.2

—

(40761511) CBC panel - Blood by Automated count

707

1.15

0.09

18.8

12.5

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

1.05

0.08

10.0

9.5

—

(3026361) Erythrocytes [#/volume] in Blood

752

0.97

0.08

36.2

18.9

4.66

4.69

e12/l

0.17

730

(3024731) MCV [Entitic volume]

752

0.97

0.08

36.1

18.9

90.34

90.77

0.37

740

(3000963) Hemoglobin [Mass/volume] in Blood

752

0.97

0.08

36.2

19.0

139.64

142.09

g/l

0.72

739

(3035941) MCH [Entitic mass]

752

0.97

0.08

36.0

18.8

30.18

30.48

0.63

740

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

1.09

0.08

1.6

1.8

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

274

0.93

0.07

3.1

2.7

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

237

0.96

0.01

3.8

3.5

—

(3013512) EKG study

178

1.01

0.00

4.4

4.1

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

135

0.96

0.00

3.0

2.3

—

(3044640) Blood type and Crossmatch panel - Blood

191

0.99

0.00

2.9

2.4

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

0.00

0.0

2.4

—

119.25

—

(3022145) Colonoscopy Study observation

0.97

0.00

1.0

1.3

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

2.3

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

2.3

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

0.00

0.0

1.1

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

0.00

0.0

1.7

—

1.00

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

0.00

0.0

1.0

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

2.3

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.1

—

(40768793) Breast Pathology biopsy report

0.00

0.0

1.6

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

0.00

-0.00

0.0

1.3

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

-0.00

0.0

1.2

—

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

0.00

-0.00

0.0

1.0

—

(3011648) Oxygen content in Venous blood

0.00

-0.00

0.0

1.7

—

11.52

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

0.00

-0.00

0.0

1.7

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

0.00

-0.00

0.0

1.4

—

8.58

—

(3007461) Platelets [#/volume] in Blood

751

0.98

-0.00

36.1

18.9

247.89

235.21

e9/l

1.08

730

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

-0.00

0.0

1.2

—

(40761536) Microorganisms panel - Urine sediment

0.98

-0.00

4.4

3.3

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

0.00

-0.00

0.0

1.2

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.3

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

0.00

-0.00

0.0

1.4

—

(3019897) Erythrocyte distribution width [Ratio] by Automated count

0.00

-0.00

0.0

1.9

—

13.00

—

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.8

—

13.85

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

0.00

-0.00

0.0

2.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

0.00

-0.00

0.0

1.2

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

0.00

-0.00

0.0

2.0

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

-0.00

0.0

1.2

—

(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

4.6

—

63.20

—

(3036603) Volume of Urine

0.00

-0.00

0.0

1.6

—

1748.00

—

(3044290) Cell count panel - Cerebral spinal fluid

0.00

-0.00

0.0

1.9

—

(3045424) Erythrocytes [Presence] in Urine

0.00

-0.00

0.0

1.0

—

(4146454) Self-monitoring of blood glucose

0.00

-0.00

0.0

1.8

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.2

—

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

0.00

-0.00

0.0

1.8

—

33.33

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

0.00

-0.00

0.0

2.0

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

0.00

-0.00

0.0

2.0

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

0.00

-0.00

0.0

1.2

—

(3004451) EKG impression Narrative

0.00

-0.00

0.0

1.4

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

0.00

-0.00

0.0

1.2

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

2.4

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

0.00

-0.00

0.0

2.2

—

(3042631) Mycobacterium sp identified in Specimen

0.00

-0.00

0.0

4.9

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

0.00

-0.00

0.0

1.1

—

(3038026) Centromere Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.2

—

(3032773) Endomysium IgG Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(21494434) Karyotype in Bone marrow

0.00

-0.00

0.0

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

-0.00

0.0

1.2

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.5

—

(3035933) Granulocytes/100 leukocytes in Blood

0.00

-0.00

0.0

1.0

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

0.00

-0.00

0.0

1.3

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

0.00

-0.00

0.0

1.4

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

2.4

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

(46235689) Lupus anticoagulant aPTT, dRVVT and PT screening panel W Reflex

0.00

-0.00

0.0

1.7

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.6

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

0.00

-0.00

0.0

1.3

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

0.00

-0.00

0.0

1.3

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

2.4

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

0.00

-0.00

0.0

2.0

—

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

0.00

-0.00

0.0

1.6

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

0.00

-0.00

0.0

2.2

—

(3023410) Appearance of Cerebral spinal fluid

0.00

-0.00

0.0

2.8

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

-0.00

0.0

1.2

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

0.00

-0.00

0.0

1.3

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.3

—

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

0.00

-0.00

0.0

1.4

—

(3044941) Cell count panel - Synovial fluid

0.00

-0.00

0.0

1.1

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

1.00

-0.00

2.8

4.5

27.00

30.63

—

(3004616) Nuclear Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.7

—

1.51

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

0.00

-0.00

0.0

1.2

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

0.00

-0.00

0.0

1.2

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

0.00

-0.00

0.0

4.4

—

147.20

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

2.4

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

0.00

-0.00

0.0

1.5

—

Mortality – FinRegistry

↥

Association

Association between endpoint F5_SEXPREF and mortality.

Females

No data

Males

No data

Mortality risk

Mortality risk for people of age

years, who have F5_SEXPREF.

N-year risk	Females	Males
1	No data	No data
5	No data	No data
10	No data	No data
15	No data	No data
20	No data	No data

Relationships between endpoints

↥

Index endpoint: F5_SEXPREF – Disorders of sexual preference

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Disorders of sexual preference

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints